Moscow, 16th July 2020: Russia plans to produce millions of doses of COVID-19 vaccine domestically this year. According to the reports from Reuters, Russia plans to produce 30 million doses of an experimental COVID-19 vaccine domestically this year, with the potential to manufacture a further 170 million abroad. The head of the country’s sovereign wealth fund told Reuters that the first human trial of the vaccine, a month-long test on 38 people, ended this week. Researchers concluded that it is safe for use and induces an immune response, though the strength of that response is as yet unclear. UN Warns of Falling Vaccination Levels due to COVID19 A larger Phase III trial involving several thousand people is expected to begin in August, said Russian Direct Investment Fund (RDIF) head, Kirill Dmitriev. “We believe that based on the current results it will be approved in Russia in August and in some other countries in September…, making it possibly the first vaccine to be approved in the world,” he said in an interview. Brazil’s Bolsonaro remains COVID-19 Positive More than 100 possible vaccines are being developed to try to stop the pandemic. At least two are in final Phase III human trials, … Continue reading COVID-19: Russia to mass-produce an experimental vaccine